Arginine kinase in Toxocara canis: Exon–intron organization, functional analysis of site-directed mutants and evaluation of putative enzyme inhibitors  by Wickramasinghe, Susiji et al.
HOSTED BY Contents lists available at ScienceDirect
Asian Paciﬁc Journal of Tropical Medicine 2016; 9(10): 995–1001 995Asian Paciﬁc Journal of Tropical Medicine
journal homepage: http://ees.elsevier.com/apjtmOriginal research http://dx.doi.org/10.1016/j.apjtm.2016.07.023✉First and corresponding author: Susiji Wickramasinghe, Department of Parasitology, Faculty of Medicine, Universi
20400, Sri Lanka.
Tel: +94 77 3114472
E-mails: susijij@pdn.ac.lk, susijijp@yahoo.co.jp
Peer review under responsibility of Hainan Medical University.
1995-7645/Copyright © 2016 Hainan Medical University. Production and hosting by Elsevier B.V. This is an open access art
creativecommons.org/licenses/by-nc-nd/4.0/).Arginine kinase in Toxocara canis: Exon–intron organization, functional analysis of site-directed
mutants and evaluation of putative enzyme inhibitorsSusiji Wickramasinghe1✉, Lalani Yatawara2, Mitsuru Nagataki3, Takeshi Agatsuma31Department of Parasitology, Faculty of Medicine, University of Peradeniya, Peradeniya 20400, Sri Lanka
2Department of Medical Laboratory Sciences, Faculty of Allied Health Sciences, University of Peradeniya, Peradeniya 20400, Sri Lanka
3Department of Environmental Health Sciences, Kochi Medical School, Oko, Nankoku City, Kochi Ken 783-8505, JapanARTICLE INFO
Article history:
Received 15 May 2016
Received in revised form 15 Jun 2016
Accepted 15 Jul 2016
Available online 10 Aug 2016
Keywords:
Toxocara canis
Arginine kinase
Gene structure
Site directed mutagenesis
Inhibition kineticsABSTRACT
Objectives: To determine exon/intron organization of the Toxocara canis (T. canis) AK
(TCAK) and to test green and black tea and several other chemicals against the activity of
recombinant TCAK in the guanidino-speciﬁc region by site-directed mutants.
Methods: Ampliﬁcation of genomic DNA fragments containing introns was carried out
by PCRs. The open-reading frame (1200 bp) of TCAK (wild type) was cloned into the
BamH1/SalI site of pMAL-c2X. The maltose-binding protein-TCAK fusion protein was
expressed in Escherichia coli TB1 cells. The purity of the expressed enzyme was veriﬁed
by SDS-PAGE. Mutations were introduced into the guanidino-speciﬁc region and other
areas of pMAL/TCAK by PCR. Enzyme activity was measured with an NADH-linked
assay at 25 C for the forward reaction (phosphagen synthesis).
Results: Arginine kinase in T. canis has a seven-exon/six-intron gene structure. The
lengths of the introns ranged from 542 bp to 2 500 bp. All introns begin with gt and endwith
ag. Furthermore, we measured the enzyme activity of site-directed mutants of the recom-
binant TCAK. TheKm value of themutant (Alanine to Serine) decreased indicating a higher
afﬁnity for substrate arginine than the wild-type. The Km value of the mutant (Serine to
Glycine) increased to 0.19 mM. The Km value (0.19 mM) of the double mutant (Alanine–
Serine to Serine–Glycine) was slightly greater than in the wild-type (0.12 mM). In addition,
several other chemicals were tested; including plant extract Azadiracta indica (A. indica),
an aminoglycoside antibiotic (aminosidine), a citrus ﬂavonoid glycoside (rutin) and a
commercially available catechin mixture against TCAK. Green and black tea (1:10 dilu-
tion) produced 15% and 25% inhibition of TCAK, respectively. The extract of A. indica
produced 5% inhibition of TCAK. Moreover, green and black tea produced a non-
competitive type of inhibition and A. indica produced a mixed-type of inhibition on TCAK.
Conclusions: Arginine kinase in T. canis has a seven-exon/six-intron gene structure.
However, further studies are needed to identify a speciﬁc compound within the extract
causing the inhibitory effect and also to determine the molecular mechanisms behind
inhibition of arginine kinase in T. canis.1. Introduction
Arginine kinase (AK) (EC: 2.7.3.3) is a member of the
phosphagen kinase family of enzymes widely distributedamong the invertebrates, protochordates, protozoa and even
bacteria [1–8]. Nematode phosphagen kinases are thought to be
arginine kinase. Generally, AKs are monomers (40 kDa), but
in some cases dimeric and also two-domain AKs resultingty of Peradeniya, Galaha Road, Peradeniya
icle under the CC BY-NC-ND license (http://
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ported [9,10]. AK catalyzes the reversible transfer of phosphate
from MgATP to arginine yielding phosphoarginine and
MgADP. Thus, AK plays an important role in cellular energy
metabolism by maintaining high ATP levels during rapid
energy demands such as muscle contraction and motility.
Further, guanidines also play a number of other roles
including, regulation of glycolysis, glycogenolysis, proton
buffering and intracellular energy transport [2,3].
Toxocara canis (T. canis) is a very common round worm
found in dogs and cats. Toxocariasis is a global zoonotic disease
caused by T. canis (dog round worm) and Toxocara cati (cat
round worm). Forms of toxocariasis include visceral larva mi-
grans, covert toxocariasis, ocular larva migrans and spinal form
(neurologic). Humans become infected by ingestion of Tox-
ocara infective (embryonated) eggs from contaminated envi-
ronments [11–14].
In 2007, we published a paper related to molecular cloning,
characterization, expression and comparison of the kinetics of
cDNA-derived AK of T. canis [2]. Recently, Sahu et al. have
done a similar study and showed 99.8% similarity with the
AK gene of T. canis [15]. In our report, we conﬁrmed the
type of phosphagen kinase present in T. canis as an arginine
kinase and its enzyme kinetics were compared with those of
other known AKs. Moreover, analysis of the N-terminus
sequence of T. canis AK (TCAK) revealed the presence of a
signal targeting peptide, presumably targeting this protein to
cytosol or endoplasmic reticulum. In 2008, we reported the
development of a highly sensitive IgG-ELISA based on re-
combinant TCAK for serodiagnosis of visceral larva migrans
in the murine model as this enzyme is not present in mammals
[16].
Only three gene structures have been reported so far in
nematode AKs: Caenorhabditis elegans (C. elegans), Brugia
malayi and Ascaris suum [1]. In the present communication,
we focus ﬁrstly on the determination of the gene structure
(exon/intron organization) of TCAK and compare it with
other known guanidino kinase gene structures in order to
elucidate their diversity in length, position, and number.
Secondly, we constructed a series of mutants, measured
the enzyme activity for the forward reaction or
phosphagen synthesis to gain greater understanding of the
role of important amino acid residues in the guanidino-
speciﬁc (GS) region.
Thirdly, several other chemicals/plant extracts were screened
to explore possibility of an inhibitory interaction between TCAK
and these substances.Table 1
Primers used to amplify the introns of T. canis AK.
Primer name
Intron1 TCPKEcoRI
TCPKnewR4
Intron2 TCPKnewF1
TCPKnewR3
Intron3 TCPKnewF2
TCPKnewR2
Intron4 TCPKnewF3
TCPKnewR1
Intron5 TCPKnewF5
TCPKnewR7
Intron6 TCPKnewF6
TCPKnewR2. Materials and methods
2.1. Genomic DNA extraction from T. canis
Genomic DNA was extracted from part of an adult worm
using an Easy-DNATM Kit according to the manufactures pro-
tocol (Invitrogen Corporation, Carlsbad, CA).
2.2. PCR ampliﬁcation of introns
Ampliﬁcation of genomic DNA fragments containing introns
was carried out by PCRs using oligonucleotide primers designed
from the complementary DNA sequence of T. canis AK [2].
Primer sequences used to amplify introns are given in Table 1.
All PCRs were carried out in a ﬁnal reaction volume of 25 mL.
Ampliﬁcations were performed with 1 mL of genomic DNA
using 1 U Ex Taq Polymerase (Takara Bio Inc., Japan), 10× Ex
Taq buffer, 0.2 mM each dNTPs and 10 pmoL of each primer.
PCR conditions used were 3 min denaturation at 94 C; 30
cycles of 30 s at 94 C; 30 s at 55 C and 5 min at 72 C;
followed by a ﬁnal 5 min extension at 68 C. All PCR reactions
were carried out in a MyCycler™ Thermal cycler (BioRad,
USA). Amplicons were visualized on 1% agarose gels stained
with ethidium-bromide. Ampliﬁed PCR products were puriﬁed
in agarose gel using GENECLEAN Ⅱ Kit. Puriﬁed PCR prod-
ucts were sub-cloned in pGEMR T-vector system (Promega,
USA). Ligated products were transformed into Escherichia coli
JM109 cells. Positive clones were obtained and plasmid DNA
extraction was performed using the alkaline SDS method.
Nucleotide sequences were determined with an ABI PRISM
3100 Avant DNA sequencer using a Big Dye Terminator v3.1
Cycle Sequencing Kit (Applied Biosystem, CA, USA).
2.3. Expression of wild-type TCAK
TCAK isoform characterized previously by Wickramasinghe
et al. was used as wild-type TCAK for the current study. It has a
theoretical molecular mass of 45376 Da and an estimated iso-
electric point (pⅠ) of 8.38 [2]. The open-reading frame (1200 bp)
of TCAK (wild type) was cloned into the BamH1/SalⅠ site of
pMAL-c2X (New England Biolabs, MA, USA). The maltose-
binding protein-TCAK fusion protein was expressed in E. coli
TB1 cells by induction with 1 mM IPTG at 25 C for 24 h. The
cells were re-suspended in 5× TE buffer, sonicated, and the
soluble protein was extracted. Recombinant fusion protein was
puriﬁed by afﬁnity chromatography using amylose resin ac-
cording to the manufactures protocol (New England Biolabs,Primer sequence (50–30)
AAGAATTCATGGCATTTCTCAAGAACCAG
CAGCCTCTGGAATGCGTCCT
TGCGGCCACTGTTAAGAAAT
ATGACATCATAGAGGGTAG
CAAATGACGTTCTCGATCAG
AAATCAGCAGTTCTACCTTC
GATAATCGAAGAATACCACG
ATCAATGCATTCTTCACCTT
TGCAGAACCAGTTGATTCA
ACCCTTCTGCATAGAAATCA
ACGTTTTTGGTGTGGGTCAA
ACCGAGATTAGTCGGACAGA
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SDS-PAGE.
2.4. Site directed mutagenesis
Mutations were introduced into the GS region and other areas
of pMAL/TCAK by PCR using oligonucleotide primers
designed based on the ORF of TCAK. The mutation 105 Ala to
Ser was introduced using the primer set: TCAK105F1 – AGC
GTG GGT GTG TAC GCT CCT GAC and TCAK105R1 –
AGA ATC CAA ATT GAA TAT GCC TGA. The mutation 106
Ser to Gly was introduced using the primer set: TCAK106F2 –
GGC GTG GGT GTG TAC GCT CCT GAC and TCAK106R2
– AGC ATC CAA ATT GAA TAT GCC TGA. The double
mutations 105 Ala to Ser and 106 Ser to Gly were introduced
using primer set: TCAK106F2 and TCAK105R1. In addition,
the mutation 321 Ser to Ala was introduced using primers:
TCAK321F – GCT ACA ATC CGT GCT TCG GTG and
TCAK321R – ACC GAG ATT AGT CGG ACA GAA. KOD
plus DNA polymerase was used as the amplifying enzyme. The
PCR products were digested with Dpn Ⅰ and then products were
puriﬁed. The kination was performed using T4 polynucleotide
kinase (10 units/mL), 5× kinase buffer, 100 mM ATP and pu-
riﬁed PCR products (after Dpn Ⅰ digestion) used as a template.
Then, DNA was self-ligated using T4 DNA ligase. Finally, all
the mutants were sequenced and it was veriﬁed that mutation
occurred at the right position of TCAK. The mutated proteins
were expressed and puriﬁed as described above.Figure 1. Comparison of the exon/intron organization (gene structure) of
TCAK.
Intron phases are shown by ‘.0’, ‘.1’, or ‘.2’ followed by the amino acid
sequence position. The conserved introns among phosphagen kinases are
shown by vertical lines (red color).
Table 2
Intron size and the sequence of exon/intron boundaries of the T. canisAK
gene.
Intron Sequence (estimated intron length)
Intron 1 GTATgtaagtgcaa (659 bp) ttgtttcagAATA2.5. Enzyme assay
Enzyme activity was measured (Ultrospec 2100 Pro, UV/
Visible Spectrophotometer, Amersham, Biosciences) with an
NADH-linked assay at 25 C for the forward reaction (phos-
phagen synthesis) [17]. Protein concentration was estimated from
the absorbance at 280 nm (0.77 AU at 280 nm in a 1 cm cuvette
corresponds to 1 mg protein/mL). The Km (Arg) value was
determined from the enzyme reaction using nine different
substrate concentrations (4, 6, 8, 10, 12, 16, 20, 25, and 30) of
L-arginine. To determine the Kd value, the above reactions
were done at four different concentrations of ATP (10, 7, 5,
and 3 mM). Ki was determined using diluted inhibitor samples
as shown in Table 4. Substrate (L-arginine) concentration was
kept at a constant level (50 mM). To estimate kinetic constants
(Km, Ki, and Kcat), a Lineweaver–Burk plot was made and ﬁtted
by the least-square method in Microsoft Excel.
2.6. Preparation of aqueous green and black tea for
inhibition studies
Commercially available Japanese green and Sri Lankan black
tea (2 g in each case) ofCamellia sinensiswere added separately to
(15–25)mL of boiled water and left for (5–10)min. Then, mixtures
were ﬁltered and precipitate was removed. The aqueous extracts
were stored at −20 C until use. Diluted (1:5, 1:10, 1:25, 1:40, and
1:50) green and black tea extracts were used in the experiments.Intron 2 AAGAgttatttctt (1423 bp) tttttcgattaagGCAG
Intron 3 TTCAgtttcatttt (819 bp) tagttttagCATA
Intron 4 CGAGgtttgctgttt (−2500 bp) gcgtctgaagATC
Intron 5 CCAAgtaagcactc (642 bp) aaaattttagGTCG
Intron 6 TTAAgtatcatctc (542 bp) ctttttgcagTCAC
Intron sequences are indicated by lower-case letters.2.7. Other products used in the inhibition studies
We tested several other commercially available chemicals
such as anthelmintics pyrantel pamoate (1 mM), ﬂubendazole(1 mM), thiabendazole (15 mM), and milbemycin (10 mM),
plant extract Azadiracta indica (A. indica) (0.3–2%), an ami-
noglycoside antibiotic aminosidine (0.1 M), a citrus ﬂavonoid
glycoside (rutin, 1 mM) and a commercially available catechin
mixture (1:2.5 dilution) (containing epicatechin, epi-
catechingallate, epigallocatechin and epigallocatechingallate)
against the TCAK. The enzyme activity was measured using
each substance separately and the data recorded. Compounds
such as anthelmintics, antibiotics and plant extract (A. indica)
were used to evaluate the inhibition kinetics against putative
arginine kinase for the ﬁrst time in the present study. However,
green tea and rutin have been used to elucidate the inhibitory
activities against AK previously.
3. Results
3.1. Exon/intron organization of T. canis AK
The exon/intron organization of TCAK was determined by
PCR ampliﬁcations using TCAK speciﬁc primers. TCAK has
the seven-exon/six-intron gene structure. Lengths of the introns
ranged from 542 bp to 2500 bp. All the introns began with gt
and ended with ag (Figure 1 and Table 2).
3.2. Kinetic constants and Vmax of site-directed mutants
We introduced site-directed mutants to the GS region of
TCAK and compared the enzyme activity of mutants with that
of the wild-type TCAK. The kinetic constants, Km
Arg, Kd
Arg, and
Vmax were determined. The Km values for single mutants (Ala
to Ser) and (Ser to Gly) were 0.07 mM and 0.19 mM,
respectively. The Km value for double mutant (Ala–Ser to Ser–
Figure 2. Lineweaver–Burk plots for inhibition of TCAK activity by green
tea.
Dilution of green tea for curves 1, 2, 3, and 4 was 1:20, 1:25, 1:40, and
1:50, respectively.
Susiji Wickramasinghe et al./Asian Paciﬁc Journal of Tropical Medicine 2016; 9(10): 995–1001998Gly) was 0.19 mM. The Kd
Arg and Vmax values for single and
double mutants were 0.28, 0.28, 0.30 mM and 35.8, 48.9,
43.7 mPi/min/mg/protein, respectively. In addition, Kd
Arg/Km
Arg
and Kd
ATP/Km
ATP values were determined for the forward reac-
tion (Table 3).
3.3. Inhibition by green and black tea on the activity of
TCAK
Green and black tea (1:10 dilution) produced 15% and 25%
inhibition of TCAK, respectively. Further, the extract of
A. indica has 5% inhibition on TCAK. However, other chem-
icals used in this study did not cause inhibition of TCAK
(Table 4).
3.4. Determination of the inhibition type of green and
black tea on TCAK
Figures 2 and 3 show the plots obtained for green and black
tea inhibition, respectively. These results clearly indicated that
the non-competitive type of inhibition occurred during the re-
actions with both, the green and black tea.
3.5. Inhibition by other products on the activity of TCAK
In addition, we tested several other chemicals such as an-
thelmintics (pyrantel pamoate, ﬂubendazole, thiabendazole, and
milbemycin), plant extract (A. indica), an aminoglycoside anti-
biotic (aminosidine), a citrus ﬂavonoid glycoside (rutin) and a
commercially available catechin mixture (containingFigure 3. Lineweaver–Burk plots for inhibition of TCAK activity by black
tea.
Dilution of green tea for curves 1, 2, and 3, was 1:10, 1:25, and 1:50,
respectively.
Table 3
Enzyme kinetics of wild-type and site-directed mutants of T. canis AK.
Source Km
Arg
(mM)
Kd
Arg
(mM)
Kd
Arg/
Km
Arg
Km
ATP
(mM)
Kd
ATP
(mM)
Kd
ATP/
Km
ATP
Vmax (mPi/min/
mg/protein)
AS-
wild
0.12 0.23 1.96 0.3 0.6 2 43.76
SSa 0.07 0.28 4 0.22 0.86 3.91 35.8
AGb 0.19 0.28 1.47 0.44 0.65 1.48 48.9
SGc 0.19 0.3 1.58 0.66 1.01 1.53 43.97
a 105 A (Ala) / S (Ser) – single mutant. b 106 S (Ser) / G (Gly).
c AS/ SG – double mutant.
Table 4
Rate of inhibition on TCAK (mM).
Inhibitor Concentrationa Substrate
(L-arginine)
concentrationa
Degree of
inhibition (Ei)
Pyrantel pamoate 1 50 −0.0537
Flubendazole 10 50 −0.037
Thiabendazole 1 50 −0.01
Milbemycin 10 50 −0.034
Aminosidine 10 50 −0.009
Azadirachta
indica
10 50 0.0539 (5%)
Black tea (Sri
Lankan origin)
1:10 50 2.452 (25%)
Green tea
(Japanese origin)
1:10 50 1.471 (15%)
Catechin mixture 0.40% 50 −0.382
Rutin 1 50 −0.084
a Unit for Inhibitor concentration and Substrate (L-arginine) concentra-
tion: mM.epicatechin, epicatechingallate, epigallocatechin and epi-
gallocatechingallate) against TCAK. Out of these chemicals
only A. indica exerts moderate inhibition (5%) on TCAK
(Table 4) and produced mixed-type inhibition during the reac-
tion (Figures 4 and 5).Figure 4. Lineweaver–Burk plots for inhibition of TCAK activity by
A. indica.
Figure 5. Amino acid sequence alignment of GS region of T. canis AK
with other phosphagen kinases.
GS region of AKs is shown in a box. Circle indicates two amino acids (Ala
110 and 111 Ser) in the GS region of T. canis and A. suum differ from other
AKs. We introduced site-directed mutants to these two amino acids
(Ala/ Ser, Ser/ Gly and Ala–Ser/ Ser–Gly).
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4.1. Comparison of exon/intron organization of T. canis
AK
We compared the gene structure of TCAK gene with those of
other AKs from the different phyla such as nematodes, trema-
todes, protozoa, and molluscs. Splice junctions (30.0), (61.0),
(99.1), and (172.2) of TCAK are conserved between TCAK and
A. suum AK (ASAK). Interestingly, intron position (99.1) is
conserved in the ASAK (nematode), BMAK (nematode), C.
elegans AK1 (nematode), Schistosoma mansoni (trematode)
two-domain TK (SMTKD1 and SMTKD2), Nautilus pompilius
(mollusc) AK (NMAK) and Anopheles gambiae (Arthropoda)
AK1. Further, the intron position (256.0) is conserved between
ASAK and BMAK. However, this splice junction differs only
by one nucleotide compared to TCAKs intron position (256.1).
Trypanosoma cruzi (T. cruzi) (protozoa) has no introns, sup-
porting the idea that it was gained by horizontal gene transfer. In
addition, it was reported that two-domain AK genes have a
bridge intron which separates the domain one from domain two
[18–20]. The structure of AK genes is highly conserved among
molluscs (six-exons and ﬁve introns) [21]. Similarly, studies on
the exon/intron organization of cytoplasmic and mitochondrial
creatine kinases have shown that splice junctions are highly
conserved. In the present study, we provided further evidencethat the AK gene structures from nematodes are highly
diverse. For instance, TCAK and ASAK have the seven-exon/
six intron and nine-exon/eight intron gene structures, respec-
tively, whereas BMAK has the six-exon/ﬁve-intron structure [1].
In addition, a number of introns and the splice junctions are less
conserved among the nematodes studied thus far. A recent study
revealed that AK gene family of the suborder Rhabditina has
undergone widespread intron loss and gain. Moreover, they
have found evidence for gene duplication and loss in C.
elegans [17]. These results suggest that a frequent loss or gain
of introns has occurred during the process of phosphagen
kinase evolution in nematodes.
4.2. Functional analysis of the site-directed mutants
The GS region, which is variable in length, is a possible
candidate for the guanidine-recognition site. There is a pro-
portional relationship between the length of the GS region in
phosphagen kinases and the mass of the guanidine substrate.
For instance, GK which uses the smallest substrate, glycocy-
amine, has no deletion. CK has only one amino acid deletion.
LK, TK, and AK each have ﬁve amino acid deletions in this
region and each recognizes relatively large guanidine sub-
strates [22]. Interestingly, SMTK and Paragonimus westermani
TK each has six amino acid deletions leading to the suggestion
that taurocyamine might not be the physiological phosphagen
substrate for the S. mansoni PK gene [23]. Nevertheless,
amino acid residues on the GS region are relatively
conserved in the AKs. But the amino acid residues Ala 110
and 111 Ser in the GS region of TCAK differ from
conserved amino acid residues. Therefore, we introduced
site-directed mutants to the GS region of TCAK and
compared the enzyme activity of mutants with that of the wild-
type TCAK. The Km value for the mutant (Ala to Ser)
decreased, indicating a higher afﬁnity for substrate arginine
than the wild-type. In contrast, the Km value for the mutant
(Ser to Gly) increased to 0.19 mM. Further, compared to the
wild-type (0.12 mM), the Km value (0.19 mM) for the double
mutant (Ala–Ser to Ser–Gly) also slightly increased. Single
mutant (Ala to Ser) shows a higher (4) synergism (Kd
Arg/Km
Arg)
compared to wild type (1.96). The Vmax value is highest
(48.9 mPi/min/mg/protein) in the mutant (Ser to Gly) and
lowest (35.8 mPi/min/mg/protein) in (Ala to Ser).
4.3. Inhibition by green and black tea on the activity of
TCAK
Phosphagen kinases play a vital role in intracellular energy
metabolism acting as a reservoir for ATP during periods in
which there is disequilibrium of ATP supply and demand. This
group of enzymes also plays a number of other roles, including
regulation of glycogenolysis, proton buffering and intracellular
energy transport [2].
In the present study, we evaluated the effects of green and
black tea on TCAK. Green and black tea (1:10 dilution) pro-
duced 15% and 25% inhibition of TCAK, respectively. Further,
the extract of A. indica has 5% inhibition on TCAK. However,
other chemicals used in this study did not cause inhibition of
TCAK. The higher rate of inhibition by black tea (in comparison
with green tea) might be due to its high content of poly phenols
and other ﬂavonoids. However, further studies are needed to
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inhibitory effect. A similar study was carried out by Paveto
et al., using green tea catechins against two different develop-
mental stages of T. cruzi [24]. The activity of the catechins on the
recombinant arginine kinase of T. cruzi was assayed. The
activity of T. cruzi AK was inhibited by about 50% at
nanomolar concentrations of catechingallate or
gallocatechingallate. However, other catechins were less
effective against T. cruzi AK.4.4. Determination of the inhibition type of green and
black tea on TCAK
Furthermore, we determined the type of inhibition using a
serial dilution (1:10, 1:25, and 1:50) of green and black tea
against the different concentrations of substrate arginine (4, 6, 8,
10, 12, 16, 20, 25, and 30 mM) under a ﬁxed concentration of
ATP (50 mM) and Lineweaver–Burk plots for green and black
tea were constructed. These results clearly indicated that the
non-competitive type of inhibition occurred during the reactions
with both, the green and black tea. On the basis of these results,
we suggest that both green and black tea inhibit recombinant
TCAK in vitro substantially and they may have antiparasitic
properties.4.5. Inhibition by other products on the activity of TCAK
We found that other chemicals used in the study (except
A. indica) did not cause inhibition of the activity of TCAK.
However, A. indica exerts moderate inhibition (5%) on TCAK.
Therefore, we determined the inhibition type using dilute sam-
ples of plant extract (A. indica) and found that these produced
mixed-type inhibition of TCAK. Moreover, Wu
et al. investigated the inhibitory interaction between rutin and
locust AK using ﬂuorescence spectroscopy and molecular
docking [25]. The results of their study indicate that rutin inhibits
locust AK and the type of inhibition is noncompetitive.
However, in this study we found that rutin did not cause
inhibition of the activity of TCAK.
Arginine kinase in T. canis has a seven-exon/six-intron gene
structure. Gene structures of nematode AKs are highly divergent
and variable, suggesting a frequent loss and gain of introns
during the course of arginine kinase evolution. Green and black
tea (1:10 dilution) produced about 15% and 25% inhibition of
TCAK, respectively. The extract of A. indica produced 5% in-
hibition of TCAK. Furthermore, green and black tea produced a
non-competitive type of inhibition and A. indica produced a
mixed-type of inhibition on TCAK. However, further studies are
needed to identify a speciﬁc compound within the extract
causing the inhibitory effect and also to determine the molecular
mechanisms behind the inhibition of arginine kinase in T. canis.Conﬂict of interest statement
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